News | Artificial Intelligence | November 30, 2019

The Swedish MedTech company will demo the machine learning capabilities of its flagship RayStation and RayCare systems

#RSNA19 The Swedish MedTech company will demo the machine learning capabilities of its flagship RayStation and RayCare systems

November 30, 2019 — Artificial intelligence and machine learning will be in the spotlight at RSNA 2019.

RaySearch operates at the cutting edge of technological innovation in the healthcare industry. The Swedish MedTech company will be present at RSNA 2019 to demonstrate machine learning and automation capabilities of its treatment planning and oncology information systems.

Machine learning capabilities in RayStation

RayStation is an innovative treatment planning system chosen by many of the leading cancer centers in the world. The system uses a classical machine learning method based on random forest for automatic plan generation, and deep neural networks (DNN) for organ segmentation. The first-ever patient treatments generated using machine learning in RayStation took place in May 2019, less than 12 months after the rollout of latest version. The system received FDA 510(k) clearance in July 2019.

Putting ecosystem thinking in practice

The latest version of RayStation comes with updates and improvements offer support for many of the leading cancer treatment machines available on the market. The goal is to actively avoid silos in the healthcare industry and harmonize treatment planning to enable better care for cancer patients worldwide.

RayCare is designed to enhance efficiency

The oncology information system RayCare offers users a digital workspace with a personalized overview and simplified management of tasks, messages and appointments. As different clinical decision points are reached during the treatment planning process, RayCare can tailor workflows accordingly. The latest version introduces RayCare Flow, a feature package designed to optimize the treatment planning process by providing automated task management for all steps in the workflow.

Flexible virtual simulation with Canon Medical

Together with our industry partner Canon Medical, RaySearch will demo its ongoing work to develop support for brachytherapy* planning and chemotherapy* prescriptions. This is a highly flexible and efficient workflow tool for virtual simulations. Demos can be booked at the RaySearch or Canon Medical booths.

For more information: www.raysearchlabs.com


Related Content

News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
News | Ultrasound Imaging

June 4, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time June 09, 2025
arrow
News | Mammography

June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the ...

Time June 09, 2025
arrow
News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
Subscribe Now